Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Search Results - Research

your search of 'Research' has 134 results.

sort by  Recent ▼
showing 1 - 15 of 134 results   
1
2
3
4
5
6
...
8
9

Research
Christmas berry could play role in fighting uveal melanoma

A chemical compound derived from the ardisia crenata plant, also known as Australian holly or Christmas berry, might be an effective tool in fighting uveal melanoma. Read more »

Research
Getting Australians thinking about Glaucoma

With the 8th World Glaucoma Congress right around the corner, CALLUM GLENNEN reports Glaucoma Australia is preparing a wealth of initiatives to improve national understanding of the condition. Read more »

Research
Rescued photoreceptors prevent blindness

After success in animal models, researchers believe they have paved the way for the first-ever human clinical trials of a stem cell based therapy for atrophic age-related macular degeneration (AMD). Read more »

Research
Faulty molecular master switch identified as possible contributing factor to AMD

Scientists from the US National Institutes of Health (NIH) have found the interruption of transforming growth factor beta (TGF-beta) signals to immune cells could be involved in the progression of age-related macular degeneration (AMD). Read more »

Research
Research finds cannabis compound ‘worsens IOP’

A study has produced conflicting results related to the use of cannabis for treating intraocular pressure amongst glaucoma patients. Read more »

Research
Spread of deadly eye tumour cells stemmed in fish

A new drug that suppresses the spread of tumour cells in zebra fish could pave the way for future treatments of childhood eye cancer. Read more »

News
New eye research receives $150,000 funding

Corneal disease, genetic testing and artificial intelligence are the focuses of three separate Centre for Eye Research Australia (CERA) projects that have received almost $150,000 in new research funding. Read more »

News
Australia-first trial for viral conjunctivitis treatment commences

An Australian trial for an adenoviral conjunctivitis treatment has begun, in what could result in a world-first treatment for the condition. Read more »

Research
Hundreds of new links found between genes and eye disease

Over 250 new links have been made between genes and vision disorders as part of a study on mouse genetics. Read more »

News
MDFA invites applications for macular disease research grants

Macular Disease Foundation Australia (MDFA) is inviting researchers and institutions to apply for its next round of research grant funding. For the first time grant criteria has been expanded to cover macular disease research, rather than solely focussing on age-related macular degeneration (AMD). Read more »

News
Fellowship for AMD researcher

Queensland Eye Institute (QEI) researcher Dr Audra Shadforth has been awarded a postdoctoral fellowship to further her studies into age-related macular degeneration (AMD). Read more »

News
Researchers find way to prevent fatal viral infection

Lions Eye Institute (LEI) researchers have discovered a new method to thwart the emergence of a life-threatening viral infection in bone marrow and organ transplant patients. Read more »

News
Potential leukaemia treatment found in eye drops

Researchers have identified an active ingredient in an eye drop currently under development that has the potential to kill leukaemia cells without harming blood cells. Read more »
Professor Robert MacLaren performs gene therapy treatment on a patient with choroideremia. Image courtesy of John Hopkins University

News
Gene therapy for incurable disease improves vision after 5 years

Choroideremia patients have gained or maintained vision five years after participating in the first gene therapy trial for the previously untreatable blinding condition. Read more »

Research
Novartis’ brolucizumab superior to aflibercept in neovascular AMD patients, study suggests

New trials have supported claims that brolucizumab is more effective than aflibercept in treating patients with neovascular age-related macular degeneration (nAMD). Read more »

sort by  Recent ▼
showing 1 - 15 of 134 results   
1
2
3
4
5
6
...
8
9


Designs for Vision
advertisement
Hot Stories

OR
 

Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!